Prostaglandin E2 as a potent therapeutic target for treatment of colon cancerVahid Karpisheh, Farhad Jadidi‐Niaragh, Afshin Nikkhoo et al.|Prostaglandins & Other Lipid Mediators|2019Cited by 126
Silencing of HIF-1α/CD73 axis by siRNA-loaded TAT-chitosan-spion nanoparticles robustly blocks cancer cell progressionFarnaz Hajizadeh, Farhad Jadidi‐Niaragh, Sadaf Moghadaszadeh Ardebili et al.|European Journal of Pharmacology|2020Cited by 76
EP4 receptor as a novel promising therapeutic target in colon cancerVahid Karpisheh, Farhad Jadidi‐Niaragh, Navneet Joshi et al.|Pathology - Research and Practice|2020Cited by 54
T‐cell immunoglobulin and ITIM domain, as a potential immune checkpoint target for immunotherapy of colorectal cancerMehrdad Fathi, Farhad Jadidi‐Niaragh, Inna Pustokhina et al.|IUBMB Life|2021Cited by 51
The molecular biology and therapeutic potential of Nrf2 in leukemiaAtefeh Khodakarami, Farhad Jadidi-Niaragh, Sara Adibfar et al.|Cancer Cell International|2022Cited by 46